# Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer

> **NCT02418624** · PHASE1 · COMPLETED · sponsor: **The Netherlands Cancer Institute** · enrollment: 25 (actual)

## Conditions studied

- Breast Cancer
- Ovarian Cancer
- Advanced Cancer

## Interventions

- **DRUG:** carboplatin, olaparib

## Key facts

- **NCT ID:** NCT02418624
- **Lead sponsor:** The Netherlands Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2019-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02418624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02418624, "Phase I of Carboplatin-Olaparib Followed by Olaparib Monotherapy in Advanced Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02418624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*